Skip to main content
Premium Trial:

Request an Annual Quote

Joseph Donahue, Steven Henikoff, Trevor Heritage, Bryan Koontz


InforSense has hired Joseph Donahue as chief business officer and president of InforSense North America. Donahue will lead the UK-based company's worldwide sales operations, and will manage its North American operations. Donahue most recently served as co-CEO of Lion Bioscience. Prior to joining Lion, he served as vice president of global life sciences and chemicals markets for Spotfire and as vice president of North American sales at MDL Information Systems.

Steven Henikoff, a biologist at the Fred Hutchinson Cancer Research Center and the University of Washington, has been elected to the National Academy of Sciences. Henikoff was recognized for inventing computational methods for analyzing DNA sequence data for the Human Genome Project.

Elsevier MDL has appointed Trevor Heritage as senior vice president of its newly created workflow business group (see story, this issue). Heritage was previously senior vice president of discovery informatics at Tripos. His position there has been filled by Bryan Koontz, the company said last month [BioInform 04-18-05].

Filed under

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.